Clinical Trial: Study on the effectiveness of Hexagonal Optimized Refractive Integration (HORI) spectacles for preventing myopia onset in pre-myopia children. (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the effectiveness of Hexagonal Optimized Refractive Integration (HORI) spectacles for preventing myopia onset in pre-myopia children.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134164

Registration Time: 2026/10/11

Type: Interventional study

Primary Sponsor: The Second People’s Hospital of Foshan

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=278505

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the effectiveness of Hexagonal Optimized Refractive Integration (HORI) spectacles for preventing myopia onset in pre-myopia children. (China)